1-2 of 2
Jose Antonio García Marco, MD
Close
Sort by
Journal Articles

The Presence Of Residual Disease After Induction and/Or Consolidation Therapy Based On Wilms’ Tumor 1 (WT1) Expression Is a Strong Prognostic Factor For Relapse and Survival In AML

Carolina Martínez-Laperche, PhD, Mi Kwon, MD, Ana Carolina Franco-Villegas, Carmen Chillón, PhD, Nerea Castro, Sandra Dolz, Carlos Rodríguez-Medina, Eduardo Anguita, MD, PhD, Nuria Perez, Miriam López-Parra, MI Prieto Conde, F Rámos Ortega, J Nicolás Rodriguez, Lourdes Hermosín, MD, Jose Antonio García Marco, MD, Maite Gómez Casares, Eva Barragan, M. González, Joaquín Martínez López, Jóse Luis Díez Martín, Ismael Buno, PhD
Journal: Blood
Blood (2013) 122 (21): 1329.
https://doi.org/10.1182/blood.V122.21.1329.1329
Published: 2013
Journal Articles

Autologous Stem Cell Transplantation with Yttriumm-90-Ibritumomab Tiuxetan (Zevalin) Plus BEAM Conditioning in Patients with Refractory Non-Hodgkin Diffuse Large B-Cell Lymphoma: Results of a Prospective, Multicenter, Phase II Clinical Trial

Javier Briones, MD, Silvana Novelli, MD, Jose Antonio Garcia Marco, MD, Jose Francisco Tomas, MD, Teresa Bernal, MD, Carlos Grande, Miguel Canales, Antonio Torres, MD, José M. Moraleda, MD, Carlos Panizo, Fernanda Palmero, MD, Isidro Jarque, MD, Miguel Hernandez, MD, Eva Gonzalez Barca, MD, Dulce Lopez, Dolores Caballero, MD
Journal: Blood
Blood (2012) 120 (21): 1978.
https://doi.org/10.1182/blood.V120.21.1978.1978
Published: 2012